Home
>
National Drug Code (NDC)
>
Cutis Compositum
Cutis Compositum - 50114-7050-1 - (LEDUM PALUSTRE TWIG and URTICA URENS and AESCULUS HIPPOCASTANUM FLOWER and GALIUM APARINE and STRYCHNOS IGNATII SEED and ARCTIUM LAPPA ROOT and PHOSPHORIC ACID and SUS SCROFA SKIN and THUJA OCCIDENTALIS LEAFY TWIG and FUMARIC ACID and SUS SCROFA UMBILICAL CORD and SUS SCROFA ADRENAL GLAND and PORK LIVER and .ALPHA.-KETOGLUTARIC ACID and SODIUM DIETHYL OXALACETATE and SUS SCROFA PLACENTA and SELENIUM and SUS SCROFA SPLEEN)
Drug Information of Cutis Compositum
| Product NDC: | 50114-7050 |
| Proprietary Name: | Cutis Compositum |
| Non Proprietary Name: | LEDUM PALUSTRE TWIG and URTICA URENS and AESCULUS HIPPOCASTANUM FLOWER and GALIUM APARINE and STRYCHNOS IGNATII SEED and ARCTIUM LAPPA ROOT and PHOSPHORIC ACID and SUS SCROFA SKIN and THUJA OCCIDENTALIS LEAFY TWIG and FUMARIC ACID and SUS SCROFA UMBILICAL CORD and SUS SCROFA ADRENAL GLAND and PORK LIVER and .ALPHA.-KETOGLUTARIC ACID and SODIUM DIETHYL OXALACETATE and SUS SCROFA PLACENTA and SELENIUM and SUS SCROFA SPLEEN |
| Active Ingredient(s): | 10; 6; 6; 13; 28; 198; 10; 6; 28; 4; 13; 6; 10; 10; 10; 6; 10; 10; 10; 8; 10; 10; 13; 8; 4 [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL & nbsp; LEDUM PALUSTRE TWIG and URTICA URENS and AESCULUS HIPPOCASTANUM FLOWER and GALIUM APARINE and STRYCHNOS IGNATII SEED and ARCTIUM LAPPA ROOT and PHOSPHORIC ACID and SUS SCROFA SKIN and THUJA OCCIDENTALIS LEAFY TWIG and FUMARIC ACID and SUS SCROFA UMBILICAL CORD and SUS SCROFA ADRENAL GLAND and PORK LIVER and .ALPHA.-KETOGLUTARIC ACID and SODIUM DIETHYL OXALACETATE and SUS SCROFA PLACENTA and SELENIUM and SUS SCROFA SPLEEN |
| Administration Route(s): | INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cutis Compositum
| Product NDC: | 50114-7050 |
| Labeler Name: | Heel Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20090430 |
Package Information of Cutis Compositum
| Package NDC: | 50114-7050-1 |
| Package Description: | 10 VIAL in 1 CARTON (50114-7050-1) > 2.2 mL in 1 VIAL |
NDC Information of Cutis Compositum
| NDC Code | 50114-7050-1 |
| Proprietary Name | Cutis Compositum |
| Package Description | 10 VIAL in 1 CARTON (50114-7050-1) > 2.2 mL in 1 VIAL |
| Product NDC | 50114-7050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LEDUM PALUSTRE TWIG and URTICA URENS and AESCULUS HIPPOCASTANUM FLOWER and GALIUM APARINE and STRYCHNOS IGNATII SEED and ARCTIUM LAPPA ROOT and PHOSPHORIC ACID and SUS SCROFA SKIN and THUJA OCCIDENTALIS LEAFY TWIG and FUMARIC ACID and SUS SCROFA UMBILICAL CORD and SUS SCROFA ADRENAL GLAND and PORK LIVER and .ALPHA.-KETOGLUTARIC ACID and SODIUM DIETHYL OXALACETATE and SUS SCROFA PLACENTA and SELENIUM and SUS SCROFA SPLEEN |
| Dosage Form Name | INJECTION |
| Route Name | INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20090430 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | Heel Inc |
| Substance Name | .ALPHA.-KETOGLUTARIC ACID; AESCULUS HIPPOCASTANUM FLOWER; ARCTIUM LAPPA ROOT; CALCIUM FLUORIDE; CORTISONE ACETATE; FORMIC ACID; FUMARIC ACID; GALIUM APARINE; ICHTHAMMOL; LEDUM PALUSTRE TWIG; MERCURIUS SOLUBILIS; PHOSPHORIC ACID; PORK LIVER; SELENIUM; SODIUM DIETHYL OXALACETATE; STRYCHNOS IGNATII SEED; SULFUR; SUS SCROFA ADRENAL GLAND; SUS SCROFA PLACENTA; SUS SCROFA SKIN; SUS SCROFA SPLEEN; SUS SCROFA UMBILICAL CORD; THALLIUM SULFATE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS |
| Strength Number | 10; 6; 6; 13; 28; 198; 10; 6; 28; 4; 13; 6; 10; 10; 10; 6; 10; 10; 10; 8; 10; 10; 13; 8; 4 |
| Strength Unit | [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL |
| Pharmaceutical Classes | Non-Standardized Animal Skin Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Cells, Epidermal [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
